Socías ME, Dong H, Wood E, Nolan S, Hayashi K, Kerr T, Milloy MJ Trajectories of retention in opioid agonist therapy and overdose risk during a community-wide overdose epidemic in a Canadian setting Am J Prev Med PubMed

Braithwaite V, Ti L, Fairbairn N, Ahamad K, McLean M, Harrison S, Wood E, Nolan S Building a hospital-based addiction medicine consult service in Vancouver, Canada: the path taken and lessons learned Addiction PubMed

Imtiaz S, Hayashi K, Nolan S An innovative acute care based intervention to address the opioid crisis in a Canadian setting Drug Alcohol Rev PubMed

Beaulieu T, Knight R, Nolan S, Quick O, Ti L Artificial intelligence interventions focused on opioid use disorders: a review of the gray literature Am J Drug Alcohol Abuse PubMed

Ickowicz S, Dong H, Ti L, Nolan S, Fairbairn N, Barrios R, Milloy MJ Behavioural, social and structural-level risk factors for developing AIDS among HIV-positive people who use injection drugs in a Canadian setting, 1996-2017 AIDS Care PubMed

Ickowicz S, Brar R, Nolan S Case study: naltrexone for the treatment of nitrous oxide use J Addict Med PubMed

Ickowicz S, Grant C, Nosova E, Boyd J, Brar R, Milloy MJ, Hayashi K, Nolan S Factors associated with the use of supervised consumption facilities among women who inject drugs in a Canadian setting J Addict Med PubMed

Giang V, Brar R, Sutherland C, Nolan S HIV treatment initiation and retention among individuals initiated on injectable opioid agonist therapy for severe opioid use disorder: a case series J Addict Med PubMed